Royalty Pharma plc (RPRX) has seen some recent activity in the stock market and its shares finished trading at $42.48 yesterday. People are starting to take notice of RPRX as the shares traded as high as $43.10 and as low as $41.30 in the prior trading day.

Royalty Pharma plc (RPRX) average trading volume is 1.00M. However, in the prior trading day Royalty Pharma plc (RPRX) exchanged 2,168,451 shares. The First downside support level on RPRX is $41.66 and the First upside resistance level on RPRX is $60.81. RPRX 50-day moving average is $41.64 and RPRX 200-day moving average is $43.85.

Royalty Pharma plc (RPRX) most recent performance has been indicated by the recent movement in RPRX shares. RPRX has performed 4.60% over the past 30 days, RPRX has performed -3.87% over the past quarter and RPRX has shown – over the past year. Royalty Pharma plc (RPRX) has a 1 year range of $38.54 to $56.50. Royalty Pharma plc (RPRX) is trading 10.22% from its 1 year low and -24.81% from its 1 year high. Royalty Pharma plc (RPRX) is showing a 1.48% short float showing the sum short in the float.

RPRX has 353.98M shares outstanding and 309.76M shares in the float. Royalty Pharma plc (RPRX) at this time has a market cap of $25.95B and income of 1.86B. The EPS next quarter for RPRX is 0.58 and projected EPS next year is 15.30%. The market cap of Royalty Pharma plc (RPRX) at $25.95B signifies how many People own shares of RPRX and is calculated off the last price ($42.48) of RPRX and the sum of shares outstanding (353.98M) with Royalty Pharma plc (RPRX).

Royalty Pharma plc (RPRX) has aggregate cash (mrq) of 2.82B, aggregate cash per share (mrq) of 7.7, aggregate debt of RPRX remains at 5.91B and aggregate debt/equity (mrq) is 62.93. . Royalty Pharma plc (RPRX) operating cash flow (ttm) is 1.86B.

RPRX is trading -0.04% below (bearish) its SMA20, 0.26% above (bullish) its SMA50 and -3.13% below (bearish) its SMA200.